97 related articles for article (PubMed ID: 18318191)
1. [Effect of medicinal preparations on the complement: inhibition of subcomponent C1q binding to a target].
Bichucher AM; Kozlov LV
Eksp Klin Farmakol; 2007; 70(6):25-8. PubMed ID: 18318191
[TBL] [Abstract][Full Text] [Related]
2. [Comparative effects of complement inhibitors in vitro and in vivo experiments: an immunoenzyme method in studying subcomponent C1q inhibition and complement inhibition in model animals].
Kozlov LV; Belkin ZP; Bichucher AM; Batalova TN; Diakov VL
Biomed Khim; 2003; 49(3):284-90. PubMed ID: 14564739
[TBL] [Abstract][Full Text] [Related]
3. Complement activation and disease: protective effects of hyperbilirubinaemia.
Basiglio CL; Arriaga SM; Pelusa F; Almará AM; Kapitulnik J; Mottino AD
Clin Sci (Lond); 2009 Oct; 118(2):99-113. PubMed ID: 19807696
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates.
Bureeva S; Andia-Pravdivy J; Symon A; Bichucher A; Moskaleva V; Popenko V; Shpak A; Shvets V; Kozlov L; Kaplun A
Bioorg Med Chem; 2007 May; 15(10):3489-98. PubMed ID: 17383882
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
Bradley AJ; Devine DV; Ansell SM; Janzen J; Brooks DE
Arch Biochem Biophys; 1998 Sep; 357(2):185-94. PubMed ID: 9735159
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic inhibition of the early phase of complement activation.
Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of the classical complement pathway by C1q-binding peptides.
Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR
J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526
[TBL] [Abstract][Full Text] [Related]
8. Importance of carbohydrate in the interaction of Tamm-Horsfall protein with complement 1q and inhibition of classical complement activation.
Rhodes DC
Immunol Cell Biol; 2006 Aug; 84(4):357-65. PubMed ID: 16594900
[TBL] [Abstract][Full Text] [Related]
9. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the ultrastructure of subcomponent C1q of human complement during spontaneous inactivation in diluted solutions].
Kozlov LV; Zinchenko AA; Sizoĭ MN; Kretova AF; Tikhonenko AS
Bioorg Khim; 1985 Jan; 11(1):37-42. PubMed ID: 3872663
[TBL] [Abstract][Full Text] [Related]
11. Isolated compounds from Sorghum bicolor L. inhibit the classical pathway of the complement.
Moon HI; Lee YC; Lee JH
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):299-302. PubMed ID: 21854169
[TBL] [Abstract][Full Text] [Related]
12. Inhibition effects of the classical pathway complement of isolated compounds from Quercus glauca.
Chung IM; Kim EH; Kim JJ; Moon HI
Hum Exp Toxicol; 2011 Sep; 30(9):1415-9. PubMed ID: 21078772
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of three oleanolic acid glycosides from Achyranthes japonica on the complement classical pathway.
Jung S; Lee JH; Lee YC; Moon HI
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):213-5. PubMed ID: 21770839
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic assay for the measurement of functional human mannose-binding lectin: a modification to avoid interference from classical pathway activation.
Herpers BL; de Jong BA; Dekker B; Aerts PC; van Dijk H; Rijkers GT; van Velzen-Blad H
J Immunol Methods; 2009 Mar; 343(1):61-3. PubMed ID: 19171151
[TBL] [Abstract][Full Text] [Related]
15. Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
Kumar P; Hair P; Cunnion K; Krishna N; Bass T
PLoS One; 2021; 16(9):e0257960. PubMed ID: 34591905
[TBL] [Abstract][Full Text] [Related]
16. Inhibition effects of isolated compounds from Artemisia rubripes Nakai of the classical pathway on the complement system.
Jung S; Lee JH; Lee YC; Moon HI
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):244-6. PubMed ID: 21854097
[TBL] [Abstract][Full Text] [Related]
17. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
18. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
Loos M
Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
[No Abstract] [Full Text] [Related]
19. Heme interacts with c1q and inhibits the classical complement pathway.
Roumenina LT; Radanova M; Atanasov BP; Popov KT; Kaveri SV; Lacroix-Desmazes S; Frémeaux-Bacchi V; Dimitrov JD
J Biol Chem; 2011 May; 286(18):16459-69. PubMed ID: 21454703
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits the classical and the alternate pathways of complement activation.
Kulkarni AP; Ghebremariam YT; Kotwal GJ
Ann N Y Acad Sci; 2005 Nov; 1056():100-12. PubMed ID: 16387680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
